You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.



Alogliptin is an orally administered anti-diabetic drug in the DPP-4 inhibitor class, developed by Syrrx, a company which was acquired by Takeda Pharmaceutical Company in 2005.

Product Details

Category Diabetes Research
Price POA
CAS Number 850649-61-5
Formula C18H21N5O2
Molecular Weight 339.39
Purity 98.0%
Appearance almost white crystalline powder
Availability In Stock
Storage Conditions +4°C

Product Enquiry

Send us your enquiry for Alogliptin. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Alogliptin email us and we will include your contribution on the website.

Enquire about product

Back to Top